NCCN Guidelines
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Guidelines
-
NCCN Guidelines Version 1.2021
- Additional Genetic Mutations
- BRCA-Related Breast and/or Ovarian Cancer Syndrome
- Breast and/or Ovarian Genetic Assessment
- Cowden Syndrome/PHTS
- Genetic/Familial High-Risk Assessment: Breast and Ovarian
- Hereditary Breast and/or Ovarian Cancer Syndrome
- Li-Fraumeni Syndrome
- Multi-Gene Testing
NCCN Guidelines in Practice™
Earn CME/CE and MOC credits for using the NCCN Guidelines to research your patient care decisions and clinical questions by clicking here.